{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:21Z","timestamp":1791488901667,"version":"4.3.4"},"reference-count":185,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020028","name":"AFNET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020028","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EHRA"},{"name":"MAESTRIA","award":["965286"],"award-info":[{"award-number":["965286"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,30]]},"abstract":"Abstract<\/jats:title>\n \n Aims<\/jats:title>\n Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET\/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA).<\/jats:p>\n <\/jats:sec>\n \n Methods and results<\/jats:title>\n Eighty-three international experts met in M\u00fcnster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/europace\/euae070","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T03:01:48Z","timestamp":1711076508000},"source":"Crossref","is-referenced-by-count":116,"title":["Longer and better lives for patients with atrial fibrillation: the 9th AFNET\/EHRA consensus conference"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-0824","authenticated-orcid":false,"given":"Dominik","family":"Linz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Center, Cardiovascular Research Institute Maastricht , Maastricht , The Netherlands"},{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G","family":"Andrade","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Vancouver General Hospital , Vancouver , Canada"},{"name":"Montreal Heart Institute , Montreal , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-6393","authenticated-orcid":false,"given":"Elena","family":"Arbelo","sequence":"additional","affiliation":[{"name":"Institut Cl\u00ednic Cardiovascular, Hospital Clinic, Universitat de Barcelona , Barcelona, Catalonia , Spain"},{"name":"Institut d\u2019Investigaci\u00f3 August Pi i Sunyer (IDIBAPS) , Barcelona, Catalonia , Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain"},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart\u2014ERN GUARD-Heart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Polyclinic of Modena , Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7574-8900","authenticated-orcid":false,"given":"Guenter","family":"Breithardt","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University Hospital , M\u00fcnster , Germany"},{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A John","family":"Camm","sequence":"additional","affiliation":[{"name":"Cardiology Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George's University of London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-8891","authenticated-orcid":false,"given":"Valeria","family":"Caso","sequence":"additional","affiliation":[{"name":"Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia , Perugia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-1653","authenticated-orcid":false,"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital and Department of Clinical Medicine , Aarhus University, Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-4183","authenticated-orcid":false,"given":"Mirko","family":"De Melis","sequence":"additional","affiliation":[{"name":"Bakken Research Center , Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-114X","authenticated-orcid":false,"given":"Tom","family":"De Potter","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, OLV Hospital , Aalst , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-2110","authenticated-orcid":false,"given":"Wolfgang","family":"Dichtl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Cardiology and Angiology, Medical University Innsbruck , Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-0857","authenticated-orcid":false,"given":"S\u00f8ren Zoega","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-117X","authenticated-orcid":false,"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Faculty of Medicine, University Hospital Essen, University Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Doll","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Sch\u00fcchtermann-Klinik , Bad Rothenfelde , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-6338","authenticated-orcid":false,"given":"David","family":"Duncker","sequence":"additional","affiliation":[{"name":"Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Dworatzek","sequence":"additional","affiliation":[{"name":"Pfizer Pharma GmbH , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3735-8503","authenticated-orcid":false,"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Department of Cardiology II\u2014Electrophysiology, University Hospital M\u00fcnster , M\u00fcnster , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-5154","authenticated-orcid":false,"given":"Christoph","family":"Eisert","sequence":"additional","affiliation":[{"name":"Preventicus GmbH , Jena , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-1733","authenticated-orcid":false,"given":"Larissa","family":"Fabritz","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"University Center of Cardiovascular Science, UHZ, UKE , Hamburg , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg\/Kiel\/L\u00fcbeck , Hamburg , Germany"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Edgbaston, Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-7712","authenticated-orcid":false,"given":"Michal","family":"Farkowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ministry of Interior and Administration, National Medical Institute , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-2454","authenticated-orcid":false,"given":"David","family":"Filgueiras-Rama","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain"},{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC), Novel Arrhythmogenic Mechanisms Program , Madrid , Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Cl\u00ednico San Carlos (IdISSC), Cardiovascular Institute , C\/ Profesor Mart\u00edn Lagos, Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-7209","authenticated-orcid":false,"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Department of Cardiology and Intensive Care Medicine, St Vincenz-Hospital Paderborn , Paderborn , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-5319","authenticated-orcid":false,"given":"Eduard","family":"Guasch","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigaci\u00f3 August Pi i Sunyer (IDIBAPS) , Barcelona, Catalonia , Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain"},{"name":"Clinic Barcelona, University of Barcelona , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Hack","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb GmbH & Co. KGaA , Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-0755","authenticated-orcid":false,"given":"St\u00e9phane","family":"Hatem","sequence":"additional","affiliation":[{"name":"IHU ICAN, Hospital Piti\u00e9-Salp\u00eatri\u00e8re , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-5054","authenticated-orcid":false,"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Department of Neurology, Universit\u00e4tsklinikum W\u00fcrzburg (UKW) , W\u00fcrzburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-7580","authenticated-orcid":false,"given":"Jeff S","family":"Healey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, McMaster University , Hamilton, Ontario , Canada"},{"name":"Population Health Research Institute , Hamilton, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-8127","authenticated-orcid":false,"given":"Hein","family":"Heidbuechel","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital, Cardiovascular Sciences, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-743X","authenticated-orcid":false,"given":"Ziad","family":"Hijazi","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital, Cardiovascular Sciences, University of Antwerp , Antwerp , Belgium"},{"name":"Department of Medical Sciences, Cardiology, Uppsala University , Uppsala , Sweden"},{"name":"Uppsala Clinical Research Center, Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas H","family":"Hofmeister","sequence":"additional","affiliation":[{"name":"Global Medical Affairs Bayer AG , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5493-3998","authenticated-orcid":false,"given":"Leif","family":"Hove-Madsen","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain"},{"name":"Biomedical Research Institute Barcelona (IIBB-CSIC) , Barcelona , Spain"},{"name":"IR Sant Pau, Hospital de Sant Pau , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Huebner","sequence":"additional","affiliation":[{"name":"Preventicus GmbH , Jena , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8824-3581","authenticated-orcid":false,"given":"Stefan","family":"K\u00e4\u00e4b","sequence":"additional","affiliation":[{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart\u2014ERN GUARD-Heart"},{"name":"Department of Medicine I, University Hospital, LMU Munich , Munich , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Munich, Munich Heart Alliance , Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-9812","authenticated-orcid":false,"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Edgbaston, Birmingham , UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Trust , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9049-546X","authenticated-orcid":false,"given":"Katarzyna","family":"Malaczynska-Rajpold","sequence":"additional","affiliation":[{"name":"Lister Hospital, East and North Hertfordshire NHS Trust , Stevenage , UK"},{"name":"Royal Brompton Hospital, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-1903","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Merino","sequence":"additional","affiliation":[{"name":"La Paz University Hospital, IdiPaz, Autonomous University of Madrid , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6818-6396","authenticated-orcid":false,"given":"Andreas","family":"Metzner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Martinistr. 52, Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-5906","authenticated-orcid":false,"given":"Llu\u00eds","family":"Mont","sequence":"additional","affiliation":[{"name":"Institut Cl\u00ednic Cardiovascular, Hospital Clinic, Universitat de Barcelona , Barcelona, Catalonia , Spain"},{"name":"Institut d\u2019Investigaci\u00f3 August Pi i Sunyer (IDIBAPS) , Barcelona, Catalonia , Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-0671","authenticated-orcid":false,"given":"Ghulam Andre","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester , Leicester , UK"},{"name":"NIHR Leicester Biomedical Research Centre , Leicester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oeff","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Cardiology Department, Medizinische Hochschule Brandenburg , Brandenburg\/Havel , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-7050","authenticated-orcid":false,"given":"Abdul Shokor","family":"Parwani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Deutsches Herzzentrum der Charit\u00e9 (CVK) , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-8495","authenticated-orcid":false,"given":"Helmut","family":"Puererfellner","sequence":"additional","affiliation":[{"name":"Cardiological Department, Ordensklinikum Linz Elisabethinen , Linz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Ravens","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Institute of Experimental Cardiovascular Medicine, University Clinic Freiburg , Freiburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-070X","authenticated-orcid":false,"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen, University of Groningen , Groningen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8429","authenticated-orcid":false,"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital , Adelaide , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-5493","authenticated-orcid":false,"given":"Daniel","family":"Scherr","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medical University of Graz , Graz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg\/Kiel\/L\u00fcbeck , Hamburg , Germany"},{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Martinistr. 52, Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-3315","authenticated-orcid":false,"given":"Ulrich","family":"Schotten","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Departments of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University , Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-5862","authenticated-orcid":false,"given":"Christian","family":"Sohns","sequence":"additional","affiliation":[{"name":"Herz- und Diabeteszentrum Nordrhein-Westfalen, Universit\u00e4tsklinik der Ruhr-Universit\u00e4t Bochum, Klinik f\u00fcr Elektrophysiologie\u2014Rhythmologie , Bad Oeynhausen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Steinbeck","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Center for Cardiology at Clinic Starnberg , Starnberg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-5895","authenticated-orcid":false,"given":"Daniel","family":"Steven","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Heart Center, Department of Electrophysiology, University Hospital Cologne , Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-0621","authenticated-orcid":false,"given":"Tobias","family":"Toennis","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg\/Kiel\/L\u00fcbeck , Hamburg , Germany"},{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Martinistr. 52, Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-1928","authenticated-orcid":false,"given":"Stylianos","family":"Tzeis","sequence":"additional","affiliation":[{"name":"Cardiology Department, Mitera Hospital , Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7579-1201","authenticated-orcid":false,"given":"Isabelle C","family":"van Gelder","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen, University of Groningen , Groningen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick H","family":"van Leerdam","sequence":"additional","affiliation":[{"name":"Royal Philips , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-5964","authenticated-orcid":false,"given":"Kevin","family":"Vernooy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Center, Cardiovascular Research Institute Maastricht , Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Medical Office, Philips Ambulatory Monitoring and Diagnostics , San Diego, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Wakili","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"Department of Medicine and Cardiology, Goethe University , Frankfurt , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK) , Partner Site Rhine-Main , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-5749","authenticated-orcid":false,"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg\/Kiel\/L\u00fcbeck , Hamburg , Germany"},{"name":"Asklepios Hospital St. Georg, Department of Cardiology and Internal Care Medicine, Faculty of Medicine, Semmelweis University Campus , Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-3763","authenticated-orcid":false,"given":"Henning","family":"Witt","sequence":"additional","affiliation":[{"name":"Pfizer Pharma GmbH , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3738-7328","authenticated-orcid":false,"given":"Stef","family":"Zeemering","sequence":"additional","affiliation":[{"name":"Departments of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University , Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0197","authenticated-orcid":false,"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET) , Muenster , Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg\/Kiel\/L\u00fcbeck , Hamburg , Germany"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Edgbaston, Birmingham , UK"},{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Martinistr. 52, Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"2024042911080408000_euae070-B1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","article-title":"Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation","volume":"389","author":"Reddy","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/eurheartj\/ehad771","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes >\/=24 hours","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","author":"McIntyre","year":"2023","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euaa279","article-title":"Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET\/EHRA consensus conference","volume":"23","author":"Fabritz","year":"2021","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: the 6th AFNET\/EHRA consensus conference","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eum191","article-title":"Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association","volume":"9","author":"Kirchhof","year":"2007","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B16","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B17","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"2024042911080408000_euae070-B18","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/heartjnl-2022-321196","article-title":"Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank","volume":"108","author":"Kany","year":"2022","journal-title":"Heart"},{"key":"2024042911080408000_euae070-B19","doi-asserted-by":"crossref","first-page":"e024214","DOI":"10.1161\/JAHA.121.024214","article-title":"Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation","volume":"11","author":"Dickow","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024042911080408000_euae070-B20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","article-title":"Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation\/atrial flutter","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","article-title":"Early rhythm control in patients with atrial fibrillation and high comorbidity burden","volume":"146","author":"Rillig","year":"2022","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/europace\/euab200","article-title":"Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST\u2014AFNET 4 trial","volume":"24","author":"Metzner","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B26","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/eurheartj\/ehac471","article-title":"Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial","volume":"43","author":"Eckardt","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jacc.2022.04.058","article-title":"Presenting pattern of atrial fibrillation and outcomes of early rhythm control therapy","volume":"80","author":"Goette","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstrom-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.2023.14685","article-title":"Atrial fibrillation catheter ablation vs medical therapy and psychological distress: a randomized clinical trial","volume":"330","author":"Al-Kaisey","year":"2023","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B31","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler","year":"2023","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B33","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1001\/jama.2022.8831","article-title":"Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial","volume":"327","author":"Marrouche","year":"2022","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B34","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200141","article-title":"Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation","volume":"1","author":"Huo","year":"2022","journal-title":"NEJM Evidence"},{"key":"2024042911080408000_euae070-B35","doi-asserted-by":"crossref","first-page":"102052","DOI":"10.1016\/j.eclinm.2023.102052","article-title":"Efficacy and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: a randomised, controlled trial","volume":"61","author":"Doll","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2024042911080408000_euae070-B36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacep.2022.12.011","article-title":"Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: a randomized controlled trial","volume":"9","author":"van der Heijden","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2024042911080408000_euae070-B37","doi-asserted-by":"crossref","first-page":"euad244","DOI":"10.1093\/europace\/euad244","article-title":"Progress in atrial fibrillation ablation during 25 years of Europace journal","volume":"25","author":"Boersma","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B38","doi-asserted-by":"crossref","first-page":"f366","DOI":"10.1093\/europace\/eux297","article-title":"Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis","volume":"20","author":"Clarnette","year":"2018","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B39","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/eurheartj\/ehad250","article-title":"A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study","volume":"44","author":"Tilz","year":"2023","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B40","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/europace\/euac050","article-title":"Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)","volume":"24","author":"Ekanem","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-023-01923-3","article-title":"Recent advances in antiarrhythmic drug therapy","volume":"83","author":"Saljic","year":"2023","journal-title":"Drugs"},{"key":"2024042911080408000_euae070-B42","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1161\/CIRCRESAHA.122.321858","article-title":"Enhanced Ca(2+)-dependent SK-channel gating and membrane trafficking in human atrial fibrillation","volume":"132","author":"Heijman","year":"2023","journal-title":"Circ Res"},{"key":"2024042911080408000_euae070-B43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-023-02679-9","article-title":"Inhibition of the K(Ca)2 potassium channel in atrial fibrillation: a randomized Phase 2 trial","volume":"30","author":"Holst","year":"2024","journal-title":"Nat Med"},{"key":"2024042911080408000_euae070-B44","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B45","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2020.23138","article-title":"Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial","volume":"324","author":"Kotecha","year":"2020","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B46","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B47","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.3390\/jcm12124028","article-title":"Left bundle branch area pacing and atrioventricular node ablation in a single-procedure approach for elderly patients with symptomatic atrial fibrillation","volume":"12","author":"Rijks","year":"2023","journal-title":"J Clin Med"},{"key":"2024042911080408000_euae070-B48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/euab232","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"24","author":"Glikson","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B49","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1093\/eurheartj\/ehac445","article-title":"Left bundle branch area pacing outcomes: the multicentre European MELOS study","volume":"43","author":"Jastrz\u0119bski","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B50","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/pace.14813","article-title":"Ablate and pace: comparison of outcomes between conduction system pacing and biventricular pacing","volume":"46","author":"Palmisano","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024042911080408000_euae070-B51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/euac201","article-title":"Conduction system pacing in everyday clinical practice: EHRA physician survey","volume":"25","author":"Kircanski","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B52","doi-asserted-by":"crossref","first-page":"G56","DOI":"10.1093\/eurheartjsupp\/suad119","article-title":"Role of conduction system pacing in ablate and pace strategies for atrial fibrillation","volume":"25","author":"Tung","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"2024042911080408000_euae070-B53","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B54","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/eurheartj\/ehu354","article-title":"Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)","volume":"35","author":"Darkner","year":"2014","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/eurheartj\/ehx666","article-title":"PulmOnary vein isolation with vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial","volume":"39","author":"Duytschaever","year":"2018","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B57","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehp235","article-title":"Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference \u2018research perspectives in AF\u2019","volume":"30","author":"Kirchhof","year":"2009","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B58","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/pace.12389","article-title":"Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden","volume":"37","author":"Charitos","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024042911080408000_euae070-B59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/europace\/eup124","article-title":"Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET\/EHRA consensus conference on atrial fibrillation entitled \u2018research perspectives in atrial fibrillation\u2019","volume":"11","author":"Kirchhof","year":"2009","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ehjdh\/ztac067","article-title":"Smartphone and wearable detected atrial arrhythmias in older adults: results of a fully digital European case finding study","volume":"3","author":"Fabritz","year":"2022","journal-title":"Eur Heart J Digit Health"},{"key":"2024042911080408000_euae070-B61","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B62","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.121.057014","article-title":"Screening for atrial fibrillation in older adults at primary care visits: VITAL-AF randomized controlled trial","volume":"145","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B63","first-page":"2302","article-title":"Anticoagulation with Edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"Reply. N Engl J Med"},{"key":"2024042911080408000_euae070-B64","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/eurheartj\/ehx731","article-title":"Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis","volume":"39","author":"Mahajan","year":"2018","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary stroke prevention in people with atrial fibrillation: treatments and trials","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol"},{"key":"2024042911080408000_euae070-B66","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B67","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B68","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B69","doi-asserted-by":"crossref","first-page":"I89","DOI":"10.1093\/eurheartjsupp\/suac079","article-title":"Ischaemic stroke in the absence of documented atrial fibrillation: is there who could benefit from anticoagulant therapy?","volume":"24","author":"Vassiliki\u2019 Coutsoumbas","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"2024042911080408000_euae070-B70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B71","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"2024042911080408000_euae070-B72","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"2024042911080408000_euae070-B73","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jacc.2014.04.019","article-title":"Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices","volume":"63","author":"Charitos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00392-021-01941-9","article-title":"Mobile health solutions for atrial fibrillation detection and management: a systematic review","volume":"111","author":"Hermans","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"2024042911080408000_euae070-B75","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.jacc.2019.09.050","article-title":"Natural history of subclinical atrial fibrillation detected by implanted loop recorders","volume":"74","author":"Diederichsen","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B76","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/europace\/euaa123","article-title":"Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B77","doi-asserted-by":"crossref","first-page":"euad058","DOI":"10.1093\/europace\/euad058","article-title":"Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study","volume":"25","author":"van de Lande","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B78","doi-asserted-by":"crossref","first-page":"euad176","DOI":"10.1093\/europace\/euad176","article-title":"The digital journey: 25 years of digital development in electrophysiology from an Europace perspective","volume":"25","author":"Svennberg","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2020.12.077","article-title":"Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation","volume":"329","author":"Hermans","year":"2021","journal-title":"Int J Cardiol"},{"key":"2024042911080408000_euae070-B80","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"key":"2024042911080408000_euae070-B81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","article-title":"Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial","volume":"5","author":"Goette","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B82","doi-asserted-by":"crossref","first-page":"e003337","DOI":"10.1161\/CIRCEP.115.003337","article-title":"Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-German atrial fibrillation competence network 1 trial","volume":"9","author":"Kuck","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B83","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jacc.2023.06.029","article-title":"Ablation to reduce atrial fibrillation burden and improve outcomes: JACC review topic of the week","volume":"82","author":"Schwennesen","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B84","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euac038","article-title":"How to use digital devices to detect and manage arrhythmias: an EHRA practical guide","volume":"24","author":"Svennberg","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2023.03.012","article-title":"Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores","volume":"261","author":"Hijazi","year":"2023","journal-title":"Am Heart J"},{"key":"2024042911080408000_euae070-B87","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B88","doi-asserted-by":"crossref","first-page":"euad226","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B89","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B90","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrcardio.2010.86","article-title":"Challenges in the classification of atrial fibrillation","volume":"7","author":"Lubitz","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"2024042911080408000_euae070-B91","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2013.05.015","article-title":"Improving outcomes in patients with atrial fibrillation: rationale and design of the early treatment of atrial fibrillation for stroke prevention trial","volume":"166","author":"Kirchhof","year":"2013","journal-title":"Am Heart J"},{"key":"2024042911080408000_euae070-B92","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature06007","article-title":"Variants conferring risk of atrial fibrillation on chromosome 4q25","volume":"448","author":"Gudbjartsson","year":"2007","journal-title":"Nature"},{"key":"2024042911080408000_euae070-B93","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"2024042911080408000_euae070-B94","doi-asserted-by":"crossref","first-page":"e003168","DOI":"10.1161\/CIRCGEN.120.003168","article-title":"Combining clinical and polygenic risk improves stroke prediction among individuals with atrial fibrillation","volume":"14","author":"O\u2019Sullivan","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2024042911080408000_euae070-B95","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCEP.114.001909","article-title":"Common genetic variants and response to atrial fibrillation ablation","volume":"8","author":"Shoemaker","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B96","doi-asserted-by":"crossref","first-page":"e007676","DOI":"10.1161\/CIRCEP.119.007676","article-title":"Genetic susceptibility for atrial fibrillation in patients undergoing atrial fibrillation ablation","volume":"13","author":"Shoemaker","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B97","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cvr\/cvad027","article-title":"Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial","volume":"119","author":"Kany","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2024042911080408000_euae070-B98","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"2024042911080408000_euae070-B99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"key":"2024042911080408000_euae070-B100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat Genet"},{"key":"2024042911080408000_euae070-B101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/clinchem.2016.255182","article-title":"Application of biomarkers for risk stratification in patients with atrial fibrillation","volume":"63","author":"Hijazi","year":"2017","journal-title":"Clin Chem"},{"key":"2024042911080408000_euae070-B102","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehy815","article-title":"Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation","volume":"40","author":"Chua","year":"2019","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B103","doi-asserted-by":"crossref","first-page":"e139179","DOI":"10.1172\/jci.insight.139179","article-title":"Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation","volume":"5","author":"Reyat","year":"2020","journal-title":"JCI Insight"},{"key":"2024042911080408000_euae070-B104","doi-asserted-by":"crossref","first-page":"euae028","DOI":"10.1093\/europace\/euae028","article-title":"Disturbed atrial metabolism, shear stress, and cardiac load after AF ablation: AXAFA biomolcules study","volume":"26","author":"Chua","year":"2024","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/eurheartj\/ehac632","article-title":"Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation","volume":"44","author":"Hijazi","year":"2023","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B106","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jacc.2017.07.758","article-title":"Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation","volume":"70","author":"King","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-physiol-031720-085307","article-title":"Dynamics of atrial fibrillation mechanisms and comorbidities","volume":"83","author":"Heijman","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"2024042911080408000_euae070-B108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol"},{"key":"2024042911080408000_euae070-B109","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00415-021-10866-2","article-title":"Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry","volume":"269","author":"Tutuncu","year":"2022","journal-title":"J Neurol"},{"key":"2024042911080408000_euae070-B110","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/eurheartj\/ehad203","article-title":"Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N","volume":"44","author":"Karl Georg","year":"2023","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B111","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.119.025350","article-title":"Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants for stroke prevention","volume":"50","author":"Paciaroni","year":"2019","journal-title":"Stroke"},{"key":"2024042911080408000_euae070-B112","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/a-2043-0346","article-title":"Factor XI inhibitors in early clinical trials: a meta-analysis","volume":"123","author":"Galli","year":"2023","journal-title":"Thromb Haemost"},{"key":"2024042911080408000_euae070-B113","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"B\u00fcller","year":"2015","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B114","author":"Bayer"},{"key":"2024042911080408000_euae070-B115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0042-1760257","article-title":"Protocol for a systematic review and individual participant data meta-analysis of randomized trials of screening for atrial fibrillation to prevent stroke","volume":"123","author":"AF SCREEN and AFFECT-EU Collaborators","year":"2023","journal-title":"Thromb Haemost"},{"key":"2024042911080408000_euae070-B116","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2020.12.002","article-title":"Individual patient data from the pivotal randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (COMBINE AF): design and rationale: from the COMBINE AF (a collaboration between multiple institutions to better investigate non-vitamin K antagonist oral anticoagulant use in atrial fibrillation) investigators","volume":"233","author":"Carnicelli","year":"2021","journal-title":"Am Heart J"},{"key":"2024042911080408000_euae070-B117","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B118","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/heartjnl-2011-300720","article-title":"Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death","volume":"98","author":"Hunter","year":"2012","journal-title":"Heart"},{"key":"2024042911080408000_euae070-B120","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2013.07.002","article-title":"Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"key":"2024042911080408000_euae070-B121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hrthm.2017.02.001","article-title":"Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: a propensity score-matched analysis","volume":"14","author":"Saliba","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024042911080408000_euae070-B122","doi-asserted-by":"crossref","first-page":"e005739","DOI":"10.1161\/CIRCEP.117.005739","article-title":"CAABL-AF (California Study of Ablation for Atrial Fibrillation): mortality and stroke, 2005 to 2013","volume":"11","author":"Srivatsa","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B123","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jce.13702","article-title":"Long-term risk of stroke and bleeding post-atrial fibrillation ablation","volume":"29","author":"Joza","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024042911080408000_euae070-B124","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The optimal anti-coagulation for enhanced-risk patients post-catheter ablation for atrial fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J"},{"key":"2024042911080408000_euae070-B126","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"2024042911080408000_euae070-B127","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B129","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B130","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B131","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B132","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Global Cardiovascular Risk","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B134","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacep.2019.05.018","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2024042911080408000_euae070-B135","doi-asserted-by":"crossref","first-page":"e007598","DOI":"10.1161\/CIRCEP.119.007598","article-title":"Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort","volume":"12","author":"Donnellan","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B136","doi-asserted-by":"crossref","first-page":"e007626","DOI":"10.1161\/CIRCEP.119.007626","article-title":"Impact of bariatric surgery on atrial fibrillation type","volume":"13","author":"Donnellan","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B137","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/europace\/euz183","article-title":"Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation","volume":"21","author":"Donnellan","year":"2019","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B138","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jce.14607","article-title":"Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation","volume":"31","author":"Donnellan","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024042911080408000_euae070-B139","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa2302392","article-title":"Daily oral GLP-1 receptor agonist orforglipron for adults with obesity","volume":"389","author":"Wharton","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B140","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMc2302677","article-title":"Semaglutide in early type 1 diabetes","volume":"389","author":"Dandona","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B141","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B142","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B143","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/heartjnl-2019-315327","article-title":"Lifestyle modifications for treatment of atrial fibrillation","volume":"106","author":"Middeldorp","year":"2020","journal-title":"Heart"},{"key":"2024042911080408000_euae070-B144","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2024042911080408000_euae070-B145","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B146","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/europace\/euab229","article-title":"A VIRTUAL sleep apnoea management pathway for the work-up of atrial fibrillation patients in a digital remote infrastructure: VIRTUAL-SAFARI","volume":"24","author":"Verhaert","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B147","doi-asserted-by":"crossref","first-page":"euad193","DOI":"10.1093\/europace\/euad193","article-title":"Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation","volume":"25","author":"van der Velden","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B148","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamacardio.2022.0810","article-title":"Mortality among patients with early-onset atrial fibrillation and rare variants in cardiomyopathy and arrhythmia genes","volume":"7","author":"Yoneda","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2024042911080408000_euae070-B149","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/ehf2.14355","article-title":"Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events","volume":"10","author":"Aziri","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2024042911080408000_euae070-B150","doi-asserted-by":"crossref","first-page":"101390","DOI":"10.1016\/j.diabet.2022.101390","article-title":"Antidiabetic agents and risk of atrial fibrillation\/flutter: a comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists","volume":"48","author":"Scheen","year":"2022","journal-title":"Diabetes Metab"},{"key":"2024042911080408000_euae070-B151","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/eurheartj\/ehab834","article-title":"Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology","volume":"43","author":"Coats","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B152","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/jce.15880","article-title":"Effect of sacubitril-valsartan on the incidence of atrial fibrillation: a meta-analysis","volume":"34","author":"Mohammad","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024042911080408000_euae070-B153","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","article-title":"Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: DELIVER trial","volume":"10","author":"Solomon","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2024042911080408000_euae070-B154","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2022.08.718","article-title":"Atrial fibrillation and dapagliflozin efficacy in patients with preserved or mildly reduced ejection fraction","volume":"80","author":"Butt","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B156","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ejhf.2861","article-title":"Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation","volume":"25","author":"Filippatos","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2024042911080408000_euae070-B157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2024042911080408000_euae070-B158","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2021.04.079","article-title":"Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes","volume":"78","author":"Filippatos","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B159","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/europace\/euac136","article-title":"The challenge of managing multimorbid atrial fibrillation: a pan-European European Heart Rhythm Association (EHRA) member survey of current management practices and clinical priorities","volume":"24","author":"Lee","year":"2022","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B160","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B161","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacep.2016.12.015","article-title":"Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation: the CENT study","volume":"3","author":"Pathak","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2024042911080408000_euae070-B162","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/eurheartj\/ehab672","article-title":"ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project","volume":"43","author":"Heidbuchel","year":"2022","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B163","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euaa279","article-title":"Dynamic risk assessment to improve quality of care in patients with atrial fibrillation. The 7th AFNET\/EHRA consensus conference","volume":"23","author":"Fabritz","year":"2021","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B164","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00399-022-00839-x","article-title":"Artificial intelligence for the detection, prediction, and management of atrial fibrillation","volume":"33","author":"Isaksen","year":"2022","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"2024042911080408000_euae070-B165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12471-019-1281-y","article-title":"Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands: CVON-AI consortium","volume":"27","author":"Benjamins","year":"2019","journal-title":"Neth Heart J"},{"key":"2024042911080408000_euae070-B166","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(22)01637-3","article-title":"Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial","volume":"400","author":"Noseworthy","year":"2022","journal-title":"Lancet"},{"key":"2024042911080408000_euae070-B167","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile photoplethysmographic technology to detect atrial fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2024042911080408000_euae070-B168","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/europace\/euad011","article-title":"Accuracy of continuous photoplethysmography-based 1 min mean heart rate assessment during atrial fibrillation","volume":"25","author":"Hermans","year":"2023","journal-title":"Europace"},{"key":"2024042911080408000_euae070-B169","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","article-title":"An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction","volume":"394","author":"Attia","year":"2019","journal-title":"Lancet"},{"key":"2024042911080408000_euae070-B170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.121.057480","article-title":"ECG-based deep learning and clinical risk factors to predict atrial fibrillation","volume":"145","author":"Khurshid","year":"2022","journal-title":"Circulation"},{"key":"2024042911080408000_euae070-B171","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1007\/s00330-022-08752-0","article-title":"Artificial intelligence-based detection of atrial fibrillation from chest radiographs","volume":"32","author":"Matsumoto","year":"2022","journal-title":"Eur Radiol"},{"key":"2024042911080408000_euae070-B172","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamacardio.2019.4004","article-title":"High-throughput, contact-free detection of atrial fibrillation from video with deep learning","volume":"5","author":"Yan","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2024042911080408000_euae070-B173","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/jcm11092636","article-title":"Outcome analysis in elective electrical cardioversion of atrial fibrillation patients: development and validation of a machine learning prognostic model","volume":"11","author":"Nu\u00f1ez-Garcia","year":"2022","journal-title":"J Clin Med"},{"key":"2024042911080408000_euae070-B174","doi-asserted-by":"crossref","first-page":"e010850","DOI":"10.1161\/CIRCEP.122.010850","article-title":"Machine learning-enabled multimodal fusion of intra-atrial and body surface signals in prediction of atrial fibrillation ablation outcomes","volume":"15","author":"Tang","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024042911080408000_euae070-B175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41591-021-01335-4","article-title":"Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial","volume":"27","author":"Yao","year":"2021","journal-title":"Nat Med"},{"key":"2024042911080408000_euae070-B176","doi-asserted-by":"crossref","first-page":"80","DOI":"10.31083\/j.fbl2703080","article-title":"Predicting ischemic stroke in patients with atrial fibrillation using machine learning","volume":"27","author":"Jung","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2024042911080408000_euae070-B177","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/eurheartj\/ehac617","article-title":"Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy","volume":"44","author":"Wouters","year":"2023","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B178","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/eurheartj\/ehab153","article-title":"Electrocardiogram screening for aortic valve stenosis using artificial intelligence","volume":"42","author":"Cohen-Shelly","year":"2021","journal-title":"Eur Heart J"},{"key":"2024042911080408000_euae070-B179","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/diagnostics13010111","article-title":"Interpretable machine learning techniques in ECG-based heart disease classification: a systematic review","volume":"13","author":"Ayano","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2024042911080408000_euae070-B180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ehjdh\/ztac038","article-title":"Improving explainability of deep neural network-based electrocardiogram interpretation using variational auto-encoders","volume":"3","author":"van de Leur","year":"2022","journal-title":"Eur Heart J Digit Health"},{"key":"2024042911080408000_euae070-B181","author":"Ribeiro"},{"key":"2024042911080408000_euae070-B182","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02303-3","article-title":"The challenges of research data management in cardiovascular science: a DGK and DZHK position paper-executive summary","author":"Steffens","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2024042911080408000_euae070-B183","doi-asserted-by":"crossref","first-page":"132","DOI":"10.15420\/aer.2020.51","article-title":"Considerations for the assessment of substrates, genetics and risk factors in patients with atrial fibrillation","volume":"10","author":"Linz","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2024042911080408000_euae070-B184","doi-asserted-by":"crossref","first-page":"782176","DOI":"10.3389\/fphys.2021.782176","article-title":"Rotor localization and phase mapping of cardiac excitation waves using deep neural networks","volume":"12","author":"Lebert","year":"2021","journal-title":"Front Physiol"},{"key":"2024042911080408000_euae070-B185","doi-asserted-by":"crossref","first-page":"704122","DOI":"10.3389\/fphys.2021.704122","article-title":"Deep learning classification of unipolar electrograms in human atrial fibrillation: application in focal source mapping","volume":"12","author":"Liao","year":"2021","journal-title":"Front Physiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/4\/euae070\/57346253\/euae070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/4\/euae070\/57346253\/euae070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T07:10:09Z","timestamp":1714374609000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae070\/7642310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":185,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae070","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,30]]},"article-number":"euae070"}}